Genetics

Study Validates Method for Nucleic-Acid Detection

Published in Gene Therapy Weekly, October 5th, 1998

Mosaic Technologies Inc., Boston, Massachusetts, announced that Acrydite is enabling researchers to use a single-step, DNA-attachment capability and a reliable high-speed DNA-hybridization process to quickly and accurately detect mutations.

"Both of these features are critically important to molecular biology researchers," said T. Christian Boles, Ph.D., Mosaic Technologies.

Acrydite, a proprietary molecule designed and developed by Mosaic Technologies for DNA immobilization and hybridization, is now being marketed to some 80,000 "bench scientists" across the United States, Canada, Mexico and Europe. Details of "Mutation Typing Using Electrophoresis...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1998-10-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry